We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Surveillance Trial Offers Peace of Mind for High-risk BRCA-carriers

News   Aug 23, 2018 | Original story sourced from University College Hospitals London

 
Avoiding Late Diagnosis of Ovarian Cancer

The ALDO (Avoiding Late Diagnosis of Ovarian Cancer) project is a partnership between UCLH Cancer Collaborative and Abcodia Ltd. The project was conceived as part of the Cancer Vanguard’s challenge to industry in 2017, to work with the NHS on projects to improve the early diagnosis of cancer. Photo credit: Pixabay

 
 
 

RELATED ARTICLES

Limitations of Health Reports From Direct-to-Consumer Genetic Tests Are Identified

News

According to study findings presented at the American Society of Human Genetics (ASHG) 2019 Annual Meeting, health reports from direct-to-consumer (DTC) genetic tests that adopt a limited variant screening approach are producing clinically false-negative results.

READ MORE

Time To Say Goodbye… to the “Household Measure” BMI?

News

A new study published in PLOS Biology sees an international collaboration of academia and industry experts introduce a novel "revolutionary" approach towards personalized and precision biomedicine, moving away from the "classic" morphometric BMI.

READ MORE

A Third "Short Sleep" Gene Has Been Discovered – And It Prevents Memory Deficits

News

In a new study, scientists have discovered a third "short sleep" gene. It is the first gene to be identified that prevents the memory deficits typically associated with sleep deprivation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE